Literature DB >> 1976421

Effects of GABA and anxiolytics on the single unit discharge of suprachiasmatic neurons in rat hypothalamic slices.

S Y Liou1, S Shibata, H E Albers, S Ueki.   

Abstract

The effects of gamma-aminobutyric acid (GABA), muscimol, baclofen and the anxiolytics; diazepam (DZP), flurazepam (FZP) and zopiclone on single-unit neural activities in the suprachiasmatic nucleus (SCN) were investigated using the rat hypothalamic slice preparation. Exposure of the slice to GABA 10(-4) M produced inhibitory responses in 65% of the 49 SCN neurons examined. The threshold concentration of GABA ranged from 10(-6) to 10(-4) M. Neurons responsive to GABA were not found to be restricted to a subdivision of the SCN, but were diffusely distributed throughout the nucleus. DZP, FZP and zopiclone produced responses similar to those of GABA. The inhibitory effects of GABA (10(-5) M) were potentiated by coadministration of DZP (10(-5) M). Muscimol and baclofen (10(-7) M to 10(-4) M) also inhibited SCN neuronal activity in a dose-dependent manner. Bicuculline (10(-5) M-10(-4) M) scarcely affected the baclofen-induced inhibition (1/6) but strongly antagonized the effects of muscimol (6/6), GABA (6/8) and DZP (4/5). These results suggest that the receptors mediating the inhibitory effects of GABA and anxiolytics within the SCN may be GABAA and/or GABAB or GABA-BDZ receptor complex, respectively.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1976421     DOI: 10.1016/0361-9230(90)90259-3

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  12 in total

1.  Orphanin-FQ/nociceptin (OFQ/N) modulates the activity of suprachiasmatic nucleus neurons.

Authors:  C N Allen; Z G Jiang; K Teshima; T Darland; M Ikeda; C S Nelson; D I Quigley; T Yoshioka; R G Allen; M A Rea; D K Grandy
Journal:  J Neurosci       Date:  1999-03-15       Impact factor: 6.167

2.  Intracellular electrophysiological study of suprachiasmatic nucleus neurons in rodents: inhibitory synaptic mechanisms.

Authors:  Y I Kim; F E Dudek
Journal:  J Physiol       Date:  1992-12       Impact factor: 5.182

Review 3.  The rhythmic GABAergic system.

Authors:  D P Cardinali; D A Golombek
Journal:  Neurochem Res       Date:  1998-05       Impact factor: 3.996

Review 4.  Collective timekeeping among cells of the master circadian clock.

Authors:  Jennifer A Evans
Journal:  J Endocrinol       Date:  2016-05-06       Impact factor: 4.286

Review 5.  Role of GABA in the regulation of the central circadian clock of the suprachiasmatic nucleus.

Authors:  Daisuke Ono; Ken-Ichi Honma; Yuchio Yanagawa; Akihiro Yamanaka; Sato Honma
Journal:  J Physiol Sci       Date:  2018-03-20       Impact factor: 2.781

6.  Modulation of mPer1 gene expression by anxiolytic drugs in mouse cerebellum.

Authors:  M Akiyama; T Kirihara; S Takahashi; Y Minami; Y Yoshinobu; T Moriya; S Shibata
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

7.  Non-rapid eye movement sleep determines resilience to social stress.

Authors:  Brittany J Bush; Caroline Donnay; Eva-Jeneé A Andrews; Darielle Lewis-Sanders; Cloe L Gray; Zhimei Qiao; Allison J Brager; Hadiya Johnson; Hamadi C S Brewer; Sahil Sood; Talib Saafir; Morris Benveniste; Ketema N Paul; J Christopher Ehlen
Journal:  Elife       Date:  2022-09-23       Impact factor: 8.713

8.  Systematic review of drugs that modify the circadian system's phase-shifting responses to light exposure.

Authors:  Robert Lee; Austin McGee; Fabian-Xosé Fernandez
Journal:  Neuropsychopharmacology       Date:  2021-12-27       Impact factor: 8.294

9.  Inhibition by 5-HT7 receptor stimulation of GABAA receptor-activated current in cultured rat suprachiasmatic neurones.

Authors:  F Kawahara; H Saito; H Katsuki
Journal:  J Physiol       Date:  1994-07-01       Impact factor: 5.182

Review 10.  The dynamics of GABA signaling: Revelations from the circadian pacemaker in the suprachiasmatic nucleus.

Authors:  H Elliott Albers; James C Walton; Karen L Gamble; John K McNeill; Daniel L Hummer
Journal:  Front Neuroendocrinol       Date:  2016-11-25       Impact factor: 8.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.